Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
about
Survival of encapsulated islets: More than a membrane storyProtein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood.Identification and characterisation of eight novel SERPINA1 Null mutationsα1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses.Comparative proteomic study reveals the molecular aspects of delayed ocular symptoms induced by sulfur mustardHepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis.Human plasma protein N-glycosylationAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.The Natural History of Lung Function in Severe Deficiency of Alpha-1 Antitrypsin Following Orthotopic Liver Transplantation: A Case Report.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Pathophysiology of Alpha-1 Antitrypsin Lung Disease.Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).Host and Environmental Factors Influencing Individual Human Cytokine Responses.Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice.Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis.Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates.Ethylene carbodiimide-fixed donor splenocytes combined with α-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts.Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.Alpha-1 antitrypsin deficiency: outstanding questions and future directions.Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation
P2860
Q26751467-D1E42FC9-6274-4E6F-B691-35C5F2D929F0Q34482148-409B03BE-80A8-4FA1-9087-E7C7C3AFD8C1Q34630059-A98DFB39-B150-41B2-A560-3561D0410B6BQ35044708-4D8CA884-B86B-4458-A19D-FF0DDA48FA45Q35562012-C73756DE-579E-42DA-96A1-A60FE1B4A17AQ36346287-EB42D238-FB38-4509-A359-22D6ECD368A3Q36963945-37F0C420-DF26-411A-BC56-38F9D46BECE5Q37173117-1C6FB264-401B-4205-9A27-6087AD5351D5Q38604663-0665A29A-2C28-4017-83E1-CC407B8C7AEAQ38643507-8CF4B8C4-78F8-4E05-9488-5D7573318C52Q38650545-2DD0CDCC-D445-4FAD-B9FC-8EE20F63B9B2Q38769762-4975FADB-5EE0-4AA2-A267-7E8F281F2061Q38798523-CDA52B18-F748-4375-9CCC-FAA185A44F32Q38937849-18DE0B6E-A0E7-4B1D-BF07-25495E0EE1F2Q39157513-C62CD65F-EB14-409B-A0E2-3EA17BEFB50EQ40726584-CBE5202D-225B-4BA5-A1E3-7C1C3B3968CEQ41507283-7F4DD416-B4C6-4A3E-AA32-321DDE386779Q41666547-7541078A-4C64-4C4C-9179-96F569F9D47EQ43851652-E4F61367-BD2D-4C6C-847B-6506969FD514Q48189143-595B8E16-8ACA-43F2-BBAF-5692A45D592DQ48904983-30A556DB-1A9A-4BB7-BDF8-010556FC9629Q51568269-50DD7894-F703-4E8D-ACDD-7AC022D37276Q55011363-C1589C33-6108-4825-AE31-58ACDD355DDDQ55666746-4CF3414F-E838-46A2-AD8E-0739F5AA3346Q57300007-9D3CC717-374B-4B2E-97C5-306475F2291EQ58603381-FC6E131C-FAE3-4E37-A179-57F8F64CDF58
P2860
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@en
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@nl
type
label
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@en
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@nl
prefLabel
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@en
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@nl
P2093
P2860
P1476
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
@en
P2093
David A Bergin
Emer P Reeves
Killian Hurley
Noel G McElvaney
P2860
P2888
P356
10.1007/S00005-012-0162-5
P577
2012-02-15T00:00:00Z